BUSSOLINO, Federico
 Distribuzione geografica
Continente #
NA - Nord America 11.582
EU - Europa 9.140
AS - Asia 3.740
AF - Africa 75
OC - Oceania 23
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.582
Nazione #
US - Stati Uniti d'America 11.364
CN - Cina 2.604
IT - Italia 1.329
IE - Irlanda 1.323
UA - Ucraina 1.132
SE - Svezia 1.104
DE - Germania 1.027
FR - Francia 878
FI - Finlandia 677
KR - Corea 602
GB - Regno Unito 581
PL - Polonia 334
CA - Canada 209
VN - Vietnam 203
AT - Austria 177
BE - Belgio 164
DK - Danimarca 148
JP - Giappone 102
RU - Federazione Russa 90
SN - Senegal 60
NL - Olanda 52
IN - India 44
HK - Hong Kong 30
TW - Taiwan 30
TR - Turchia 25
CH - Svizzera 23
NO - Norvegia 20
GR - Grecia 19
IR - Iran 19
SA - Arabia Saudita 19
AU - Australia 16
UZ - Uzbekistan 13
RO - Romania 12
ES - Italia 9
MX - Messico 9
PH - Filippine 9
SG - Singapore 9
TH - Thailandia 8
BY - Bielorussia 7
EU - Europa 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
ZA - Sudafrica 7
CL - Cile 6
ID - Indonesia 6
BR - Brasile 5
RS - Serbia 5
CZ - Repubblica Ceca 3
EE - Estonia 3
HU - Ungheria 3
IL - Israele 3
MY - Malesia 3
NG - Nigeria 3
AL - Albania 2
BG - Bulgaria 2
HR - Croazia 2
IQ - Iraq 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CO - Colombia 1
EG - Egitto 1
GE - Georgia 1
IS - Islanda 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MN - Mongolia 1
PK - Pakistan 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
VE - Venezuela 1
Totale 24.582
Città #
Beijing 1.874
Chandler 1.787
Dublin 1.320
Ann Arbor 804
Jacksonville 730
Houston 636
Villeurbanne 595
Fairfield 572
Torino 416
Medford 415
Princeton 408
Woodbridge 407
Dearborn 380
Nyköping 345
Wilmington 337
Warsaw 318
Ashburn 272
Cambridge 198
Seattle 189
Milan 184
Vienna 172
Boston 154
Brussels 153
Pisa 140
Fremont 137
Boardman 131
Toronto 131
Dong Ket 116
Verona 82
Falls Church 68
Guangzhou 68
Turin 66
Norwalk 65
Redwood City 65
Hefei 59
Shanghai 59
San Mateo 53
Nanjing 52
Lachine 48
Jinan 41
Kunming 41
San Diego 38
Hangzhou 37
Washington 31
Düsseldorf 30
Taipei 25
Wuhan 23
Xian 23
Padova 22
London 20
Monmouth Junction 20
Redmond 20
Changsha 19
Hebei 18
Mountain View 18
Philadelphia 17
Phoenix 17
Saint Petersburg 17
Sanayi 17
Nanchang 16
Zhengzhou 16
Chengdu 15
Tokyo 15
Chicago 14
Dammam 14
Fuzhou 14
Piemonte 14
Seoul 14
Upper Marlboro 14
New York 13
Stavanger 13
Munich 12
Rome 12
San Jose 12
Shenyang 12
Bruehl 11
Tappahannock 11
Ardabil 10
Auburn Hills 10
Central District 10
Los Angeles 10
Tianjin 10
Amsterdam 9
Chongqing 9
Dallas 9
Detroit 9
Silver Spring 9
Bangkok 8
Napoli 8
Ottawa 8
San Francisco 8
Athens 7
Buffalo 7
Cumiana 7
Edinburgh 7
Groningen 7
Leiden 7
Moncalieri 7
Zurich 7
Changchun 6
Totale 14.931
Nome #
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment 441
Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2 366
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer 289
A transient kinetic study between signaling proteins: the case of the MEK–ERK interaction 263
Semaphorins in cardiovascular medicine. 240
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 233
Diacylglycerol kinase-alpha phosphorylation by Src on Y335 is required for activation, membrane recruitment and Hgf-induced cell motility. 232
CCL16 activates an angiogenic program in vascular endothelial cells 215
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 204
Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 189
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination 181
A peptide from the extracellular region of the synaptic protein α Neurexin stimulates angiogenesis and the vascular specific tyrosine kinase Tie2 162
Modulation of Angiopoietin 2 release from endothelial cells and angiogenesis by the synaptic protein Neuroligin 2 157
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice 156
Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer 155
A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis 155
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia 151
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 144
The neuronal pentraxin-2 pathway is an unrecognized target in human neuroblastoma which also offers prognostic value in patients 144
PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations 143
Real-time monitoring of cell protrusion dynamics by impedance responses 139
Differential regulation of neurexin at glutamatergic and GABAergic synapses. 137
TFEB controls vascular development by regulating the proliferation of endothelial cells 134
Simplification of a complex signal transduction model using invariants and flow equivalent servers 133
Activation of endothelial guanylate cyclase inhibits cellular reactivity. 124
Fluorescence anisotropy analysis of protein-antibody interaction 118
Neuroligin 1 induces blood vessel maturation by cooperating with the α6 integrin. 118
A study of the interaction between fluorescein sodium salt and bovine serum albumin by steady-state fluorescence 115
Nervous vascular parallels: axon guidance and beyond 111
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets. 111
Tumor progression: the neuronal input 108
Abstract 5620: Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings 107
Evidence for a role of the Na+/H+ exchanger in the colony-stimulating-factor-induced ornithine decarboxylase activity and proliferation of the human cell line M-07e. 106
Effect of inhibiting the sterol biosynthesis pathway and the cholesterol content in the regulation of angiogenesis in vitro and in vivo 106
A novel mechanism of HIV-1 entry into host cells and peptides inhibiting this mechanism 105
Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor. 105
A complex of α6 integrin and E-cadherin drives the liver metastasis of colorectal cancer cells by a physical and functional interaction with hepatic angiopoietin-like 6 105
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program 105
An anti-inflammatory protein secreted from the rat seminal vesicle epithelium inhibits the synthesis of platelet-activating factor and the release of arachidonic acid and prostacyclin. 104
Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. 104
The miR-126 regulates Angiopoietin-1 signaling and vessel maturation by targeting p85β 104
A study of the interaction between fluorescein sodium salt and bovine serum albumin by steady-state fluorescence 103
A computational model for eukaryotic directional sensing 102
Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells 101
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro 100
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 100
Abstract 1163: Microenvironment targets in KRAS-mutated metastatic colorectal cancer 99
Angiogenesis: prognostic significance in laryngeal cancer. 98
Vasculogenic potential of long term repopulating cord blood progenitors 98
Human alpha-thrombin induces phosphoinositide turnover and Ca2+ movements in cultured human umbilical vein endothelial cells. 96
Role of Na+/H+ exchange in the granulocyte-macrophage colony-stimulating factor-dependent growth of a leukemic cell line M07e. 96
Human GM-CSF in vivo: identification of the target cells and of their kinetics of response. 94
Human endothelial cells are targets for platelet-activating factor (PAF).Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF. 93
Consensus guidelines for the use and interpretation of angiogenesis assays 93
Biological aspects of tumour angiogenesis 92
KRAS-driven metabolic rewiring reveals novel actionable targets in cancer 92
A new computational approach to analyze human protein complexes and predict novel protein interactions 91
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 91
Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy 91
Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: comparison between tumor necrosis factor alpha and beta and interleukin-1. 90
MicroRNA-mediated regulatory circuits: outlook and perspectives 90
Identification of CD36 molecular features required for its in vitro angiostatic activity. 89
On the use of stochastic Petri nets in the analysis of Signal Transduction Pathways for Angiogenesis process 89
Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma 88
Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons. 86
Gene expression profiling of HMGB1-stimulated endothelial cells: a balancing act between angiogenesis and inflammation 86
Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis 86
LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms 86
Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells. 84
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy 84
The R-Ras/RIN2/Rab5 complex controls endothelial cell adhesion and morphogenesis via active integrin endocytosis and Rac signaling 84
Small GTPase Rab5 participates in chromosome congression and regulates localization of the centromere-associated protein CENP-F to kinetochores. 84
Recombinant AAV vector encoding human VEGF165 enhances wound healing. 83
3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner 83
Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma 83
Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. 82
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. 82
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 82
SPAD aptasensor for the detection of circulating protein biomarkers 82
Target cells for GM-CSF and kinetics of response. 81
A simulation environment for directional sensing as a phase separation process 81
Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies. 81
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells. 81
A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. 80
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival 79
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. 79
MRCKalpha is activated by caspase cleavage to assemble an apical actin ring for epithelial cell extrusion 79
Acetylcholine and dopamine promote the production of platelet activating factor in immature cells of chick embryonic retina. 78
Unraveling the influence of endothelial cell density on VEGF-A signaling 78
Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells. 77
Stimulation of the Na+/H+ exchanger in human endothelial cells activated by granulocyte- and granulocyte- macrophage-colony-stimulating factor. Evidence for a role in proliferation and migration. 77
Besides adhesion: new perspectives of integrin functions in angiogenesis 77
Role of Na+/H+ exchange in thrombin-induced platelet-activating factor production by human endothelial cells. 77
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages 77
Therapy for cancer: Strategy of combining anti-angiogenic and target therapies 77
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 77
Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells. 75
Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. 75
Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells 75
Semaphorins and tumor angiogenesis 75
Totale 11.688
Categoria #
all - tutte 57.434
article - articoli 0
book - libri 0
conference - conferenze 4.363
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.797


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.871 0 0 0 97 86 297 38 252 97 330 528 146
2019/20203.753 94 172 295 265 257 638 499 259 466 336 291 181
2020/20213.264 249 220 319 202 315 170 257 115 463 329 213 412
2021/20223.646 173 176 172 190 134 180 321 182 134 319 778 887
2022/20235.399 589 374 110 460 556 1.303 504 357 615 102 300 129
2023/2024894 340 409 143 2 0 0 0 0 0 0 0 0
Totale 25.587